Home > Oncology > Adjuvant likely bests salvage radiation in high-risk prostate cancer

Adjuvant likely bests salvage radiation in high-risk prostate cancer


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Journal
Journal of Clinical Oncology
Reuters Health - 14/06/2021 - Adjuvant radiation following radical prostatectomy (RP) seemed more effective in reducing all-cause mortality (ACM) than salvage radiation in men with high-risk prostate cancer in a large retrospective study. "The study will likely change the standard of care," Dr. Anthony D'Amico of Brigham and Women's Hospital in Boston told Reuters Health by phone. "Three randomized trials published in September 2020 concluded that delivering radiation therapy (RT) after surgery...when the PSA rises signaling recurrence (i.e., early sRT), as opposed to when the PSA is undetectable (i.e., adjuvant RT), did not compromise subsequent cancer progression." (https://bit.ly/36zmPEx https://bit.ly/3gmpmq5 and https://bit.ly/36yZ6o1) "So now, no one is referr...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on